Alexandra Danel
DVM
Dr. Danel is a neurology and neurosurgery resident at Mississippi State University. She completed her DVM degree at the University of Minnesota in 2018. She went on to complete a small animal rotating internship at Tufts University and 2 neurology and neurosurgery specialty internships at VCA Shoreline. Her professional interests include traumatic brain injury, spinal stabilization surgery, and refractory seizures.
Read Articles Written by Alexandra DanelAndy Shores
DVM, MS, PhD, DACVIM (Neurology)
Dr. Shores is the chief of neurosurgery and neurology at the Mississippi State University College of Veterinary Medicine. He received his DVM degree from Auburn University in 1977, completed a residency in surgery at Purdue University along with a master’s degree, and completed a neurology/neurosurgery residency with a PhD at Auburn University. He is a diplomate of the American College of Veterinary Internal Medicine (ACVIM) with a neurosurgery specialty and holds a Neurosurgery Certificate of Training from the ACVIM. He is the author of more than 100 publications and editor of the first book dedicated entirely to veterinary neurosurgery. His professional interests include spinal fixation, intracranial surgery, and intervertebral disk disease.
Read Articles Written by Andy Shores
Traumatic brain injury (TBI) is a frequent component of head trauma in small animals. The most common cause is motor vehicle accidents in dogs and crush injuries in cats. In humans, guidelines for TBI treatment are focused on maintaining cerebral perfusion, reducing intracranial pressure, and treating secondary injury. In veterinary medicine, most clinical recommendations are drawn from human studies and clinical experience.
To maximize the chance of recovery, expedient and aggressive therapy must be initiated. Treatment includes addressing life-threatening injuries first, followed by supportive care, and in some cases surgery. Prognosis can be best estimated using the Small Animal Coma Scale. Hypotension, and thus reduced cerebral perfusion pressure, is a negative prognostic indicator. This article reviews the pathophysiology of head trauma, patient assessment, diagnostic testing, treatment recommendations, monitoring, and prognosis.
Take-Home Points
- Traumatic brain injury is a frequent component of head trauma in small animals, with the most common cause being motor vehicle accidents in dogs and crush injuries in cats.
- Life-threatening injuries should be addressed first (airway, breathing, circulation), along with correcting hypovolemia and maintaining adequate oxygenation and ventilation.
- A noncontrast computed tomography scan should be performed when available to identify fractures, damage to brain parenchyma, and hemorrhage/hematomas, as well as signs of brain herniation. Skull radiographs are not accurate for ruling out fractures and lack soft tissue detail.
- Treatment is mostly supportive and aims to maintain cerebral perfusion, treat secondary injury, and reduce increased intracranial pressure.
- Maintaining a mean arterial pressure ≥90 mm Hg (systolic ≥100 mm Hg) and an oxygen saturation ≥95% are key components of initial therapy.
- Decompressive surgery is recommended for removal of epidural or subdural hematomas, compressive skull fractures, removal of foreign materials lodged into the brain parenchyma, achieving hemostasis, and decompression for progressive neurologic deterioration.
- Hyperglycemia, hypovolemia, and thus reduced cerebral perfusion pressure, and a low Small Animal Coma Scale (SACS) score (<8) are negative prognostic indicators.
- Performing an Animal Trauma Triage score and serial SACS evaluations is the best way to estimate outcomes.
Traumatic brain injury (TBI) is a frequent component of head trauma in small animals. TBI is associated with high morbidity and mortality in both animals and humans. Etiologies are most commonly motor vehicle accidents in dogs and crush injuries in cats.1 Falls from heights, gunshot wounds, bite wounds, and accidental or purposeful attacks from humans are other causes. Recovery is enhanced by early and aggressive therapy. Treatment is focused on maintaining cerebral perfusion pressure (CPP), reducing intracranial pressure (ICP), and treating secondary injury. This article reviews the pathophysiology of head trauma, patient assessment, diagnostic testing, treatment recommendations, monitoring, and prognosis.
Pathophysiology of Head Trauma Patients
Increased Intracranial Pressure
Mean arterial pressure (MAP) minus ICP is the CPP. The Monro–Kellie doctrine states that the volume of brain parenchyma, blood, and cerebrospinal fluid is constant, and any change in volume without compensation leads to an increase in ICP. Usually, there is a high intracranial compliance and a minimal effect on ICP with fluid shifts in the brain vasculature and cerebrospinal fluid.
When the volume-buffering capacity is exceeded beyond the limits of compensatory mechanisms, the ICP will increase. Increased ICP leads to a decrease in CPP, cerebral ischemia, and neuronal death. Severe increases in ICP trigger a cerebral ischemic response called the Cushing reflex (manifested as hypertension with bradycardia) in an attempt to maintain appropriate CPP. The Cushing reflex occurs with an acute and severe increase in ICP, which results in a decrease in cerebral blood flow and thus an increase in carbon dioxide. The Cushing reflex occurs in terminal stages of brain herniation and is indicative of possible life-threatening elevations in ICP; thus, aggressive treatment should be initiated. Prior to this stage, there is likely failure of other hemostatic mechanisms related to Pco2 (partial pressure of carbon dioxide), blood pressure, cerebral metabolic rate, and pressure autoregulation.
Primary Brain Injury
Primary brain injury is the direct physical damage from the traumatic event. Injuries range from mild contusion to severe laceration of the brain parenchyma. Vasculature damage may also lead to intracranial hemorrhage, hematoma formation, and subsequent vasogenic edema. Unstable skull fractures can contribute to primary injury as well.2-5
Secondary Brain Injury
A complex cascade of biochemical derangements causes secondary injury within minutes to days after the initial trauma. Trauma causes increased release of excitatory neurotransmitters and depletion of adenosine triphosphate. A sudden influx of sodium and calcium into cells leads to a further increase in excitatory neurotransmitters. Increases in sodium lead to cytotoxic edema along with failure of membrane pumps, whereas increases in calcium lead to neuronal damage and death. Local tissue acidosis and hypoperfusion trigger production of reactive oxygen radicals, which damage the neuronal cell membranes. TBI also causes release of inflammatory cytokines, which accumulate in tissues and worsen secondary injury by activating the arachidonic acid and coagulation cascades, thus damaging the blood–brain barrier (BBB). Inflammation leads to release of nitric oxide, which leads to excessive vasodilation and loss of pressure autoregulation. Cerebral perfusion is compromised with systemic changes such as hypotension, hypoxia, inflammation, changes in glucose concentrations, hyperthermia, electrolyte abnormalities, acid–base abnormalities, and hypercapnia or hypocapnia.6-9
Assessment of Head Trauma Patients
Primary Assessment and Extracranial Stabilization
Life-threatening extracranial injuries are evaluated first (ABCs [airway, breathing, circulation]). An electrocardiogram and blood pressure test are part of the triage exam. If the animal is in shock, the clinician should immediately address hypotension, hypovolemia, and oxygenation/ventilation. Hypovolemia and hypoxemia strongly correlate with an increased ICP and mortality.6
The Animal Trauma Triage (ATT) scoring system was developed using 6 categories: perfusion, cardiac, respiratory, eye/muscle/integument, skeletal, and neurologic. Each category is scored on a scale of 0 to 3, with 0 indicating mild to no injury and 3 indicating severe injuries. The score for each category is added to give a maximum total ATT score of 18. The ATT was initially developed in 1994, and it was found that each point on the scale resulted in a 2.3 to 2.6 decreased likelihood of survival.10 Since then, several studies have validated this scoring system.11-14
A newer veterinary trauma score, VetCOT (Veterinary Committee on Trauma), has been developed that uses 4 predictive variables: blood ionized calcium and plasma lactate concentration within 6 hours of admission, and presence or absence of head and/or spinal trauma. However, further validation studies are needed for this scoring system.15
Neurogenic pulmonary edema can develop rapidly following a TBI, causing dyspnea, hypoxemia, and hypercapnia, and therefore potentially increased ICP. The pathophysiology is not well understood, but it is thought to be due to a marked peripheral vasoconstriction secondary to an increase in sympathoadrenal activity. The vasoconstriction is then thought to lead to systemic hypertension and pulmonary capillary hypertension with subsequent edema. Neurogenic pulmonary edema is typically self-limiting and resolves within hours to days. Early intervention and aggressive supportive therapy are important. This consists of employing therapies that improve oxygenation and support of respiratory function (e.g., oxygen mask, oxygen cage, oxygen via nasal catheter), minimizing stress with use of light sedation as needed, and administering diuretics (furosemide 2 to 4 mg/kg IV q4h to q12h) in the acute phase. Intubation and positive-pressure ventilation are recommended for critically dyspneic animals.16-19
Hyperthermia may be noted as a result of trauma to the thermoregulatory center, iatrogenic causes, stress, seizures, or pain. Hyperthermia should be addressed immediately as it increases cellular metabolism and vasodilation, which may lead to an increase in ICP.20
After addressing life-threatening injuries, the patient should be fully evaluated for other injuries (e.g., fractures, thoracic or abdominal injuries).
Neurologic Assessment and Intracranial Stabilization
A full neurologic exam and a Small Animal Coma Scale (SACS) evaluation, also known as the modified Glasgow Coma Scale (MGCS), should be performed next (FIGURE 1).21 The SACS evaluates motor activity, brainstem reflexes, and level of consciousness, with a total score of 18. A lower score is associated with a poorer prognosis. The idea of a SACS was derived from the work of Teasdale and Jennett, who developed the Glasgow Coma Scale (GCS) in humans. Although much of the GCS relies on verbal responses in humans, the SACS delivers scores based on physical and neurologic responses that are evaluated or observed. The result is an objective measurement of the patient’s status. SACS assessment helps the clinician assess severity of neurologic status and initial prognosis; it also allows the clinician to perform serial SACS scores to monitor for improvements or deteriorations.2

Figure 1. Small Animal Coma Scale. Evaluations are made of each category and the composite score can be used to estimate patient outcome.
Hyperosmolar therapy (mannitol, hypertonic saline) is the treatment of choice for reducing ICP in patients with TBI. Hypertonic saline may be favored over mannitol because it significantly decreases ICP to a greater degree and for a longer duration compared with mannitol22; however, the Brain Trauma Foundation guidelines in human medicine still consider mannitol as first-line treatment in patients with TBI if the patients are euvolemic and preferably normotensive.23 Hypertonic saline may also be a better choice for hypovolemic patients, although hypernatremia is a contraindication for use. Dose recommendations for hypertonic saline are 3 to 4 mL/kg (7.5% sodium chloride [NaCl]) and 5.3 mL/kg (3% NaCl). The dose recommendation for mannitol is 0.5 to 1.5 g/kg as a bolus over 15 to 20 minutes; however, one study in humans showed that a higher dose (1.4 g/kg) showed significantly better outcomes when compared to a lower dose (0.7 g/kg).24 The lower concentration of hypertonic saline (3%) is preferred when using a peripheral vein because the higher concentration (7.5%) usually causes a severe vasculitis.
In addition to hyperosmolar therapy, elevating the head at a 15° to 30° angle with the head and neck extended helps reduce cerebral blood volume by increasing venous drainage from the brain. This helps decrease the ICP and increase the CPP. Care must be taken to avoid compression of the jugular veins, which leads to an increase in ICP.2,25
If the patient is actively having seizures, diazepam or midazolam is the first-line treatment for rescue (diazepam 0.5 to 1 mg/kg IV or midazolam 0.3 to 0.5 mg/kg IV or intranasally). The dose can be repeated up to 4 times in an hour. For prevention of further seizure activity, a maintenance anticonvulsant medication should be started after a seizure. Levetiracetam is a good option. It has low sedative properties and is less likely to interfere with serial neurologic assessments. The loading dose of levetiracetam is 60 mg/kg IV, followed by 30 mg/kg IV q8h. Levetiracetam should be administered diluted as per the package insert and given slowly over 15 minutes to avoid possible severe and life-threatening adverse reactions.26 Prolonged seizure activity can cause hypoxemia secondary to noncardiogenic pulmonary edema or aspiration pneumonia.19 It can also cause cerebral edema and hyperthermia. Prompt and aggressive treatment of seizures is very important.
Diagnostic Testing for Head Trauma Patients
During triage, emergency diagnostic testing should include blood pressure, packed cell volume, total protein, blood glucose, electrolytes, coagulation screening, and urine specific gravity. Point-of-care thoracic ultrasound is recommended to identify pleural effusion, pneumothorax, and pulmonary contusions. After life-threatening abnormalities are addressed, a full complete blood count, chemistry panel, and thoracic and abdominal radiographs are indicated. If available, a full-body computed tomography (CT) scan can be considered in lieu of other imaging modalities for evaluating limbs, the vertebral column, and thoracic and abdominal cavities.1,2,27-29
When evaluating head injury, noncontrast CT is the gold standard diagnostic test in humans because it helps clinicians identify fractures, damage to brain parenchyma, hemorrhage/hematomas, and signs of brain herniation.3 A helpful feature of CT is 3-dimensional reconstruction, which helps with visualization of the extent of the fracture and aids in surgical planning (FIGURE 2). A magnetic resonance imaging (MRI) scan is typically more sensitive for subtle lesions, but it requires general anesthesia, images bone poorly, and is often not available in general practices.30 CT is faster, less expensive, and better at visualizing fractures and peracute hemorrhage; in addition, it requires sedation rather than anesthesia.4 Chai et al developed the Koret CT score (KCTS), which is a 7-point prognostic scale using CT scan findings. The score includes points for hemorrhage, midline shift or lateral ventricle asymmetry, cranial vault fracture, depressed fracture (1 point each), and infratentorial lesion (3 points).31 If advanced imaging of the head is not available, skull radiographs may be helpful in identifying skull fractures, but they are not helpful in evaluating the brain parenchyma.2
Treatment of Head Trauma Patients
Medical Therapy
Intravenous Fluid Therapy
The main goal of fluid therapy is to promptly correct hypovolemia and/or hypotension to maintain adequate CPP. Aggressive fluid therapy was once thought to worsen brain edema; however, it is now contraindicated to volume-limit TBI patients. Hypotension is a negative outcome predictor causing increased ICP and mortality in humans. A human study showed that 1 episode of hypotension in patients with a systolic blood pressure of <90 mm Hg was linked to a 150% increase in mortality.32
Although no specific guidelines for the type of fluids used in patients with TBI exist, there are several options, including isotonic crystalloids, hypertonic crystalloids, artificial colloids, and blood products. In a healthy animal, the BBB is permeable to water, but almost impermeable to ions and colloids due to tight intercellular junctions. However, after injury, the BBB may be disrupted, which may result in increased nonselective permeability to ions and colloidal particles.33 Overly aggressive fluid resuscitation may increase cerebral edema; however, a more important concern is restoring and maintaining CPP.
Dose recommendations for fluid therapy include quarter shock doses (based on a shock volume of 90 mL/kg in dogs and 60 mL/kg in cats) given rapidly for isotonic crystalloids (e.g., lactated Ringer solution, 0.9% saline). Synthetic colloids can be used at 10 to 20 mL/kg in dogs (max 40 mL/kg/hr) rapidly or 5 mL/kg in cats slowly over 5 to 10 minutes. Fluid therapy should be continued until adequate tissue perfusion is reached (i.e., normal heart rate, blood pressure, pulse quality, mucous membrane color, capillary refill time).
Hypertonic saline (4 mL/kg [7.5% NaCl] and 5.3 mL/kg [3% NaCl]) is another option for correcting hypovolemic/hypotensive shock, but the duration of action is only 15 to 75 minutes. Hypertonic saline boluses should always be followed with at least a maintenance rate of isotonic crystalloids.
Oxygenation and Ventilation
Decreased cerebral oxygen delivery is the main perpetrator of secondary brain injury. Pulse oximetry is a good way of determining oxygenation status; however, blood gas analysis is ideal. An oxygen saturation (Spo2) ≥95% is normal and reflects an arterial partial pressure of oxygen (Pao2) of ≥80 mm Hg. An Spo2 of <89% is indicative of severe hypoxemia and reflects a Pao2 of <60 mm Hg. When blood gas analysis is available, the Pao2 should be maintained at ≥90 mm Hg. Oxygen supplementation is often necessary.34,35
Anticonvulsants
Seizures are common in humans after a TBI, with an incidence of 54%.36 In veterinary patients, the incidence is thought to be lower, at 6% to 36%, depending on the study.23,37,38 Seizures after a TBI can be immediate (within 24 hours of TBI), early (24 hours to 7 days after TBI), and later (>7 days after TBI). In human patients, prophylactic administration of some antiseizure medications (e.g., phenytoin, valproate) reduces the risk of immediate and early seizures; however, these medications are not used in veterinary patients due to their very short half-life.19,39,40 Although levetiracetam does not have enough evidence to support its efficacy for preventing immediate and early posttraumatic seizures in humans, it may be indicated for use in veterinary patients for at least 7 days after a TBI because it is relatively safe and nonsedating.40
Corticosteroids
Corticosteroids are contraindicated in patients with a TBI because it has been proven that they increase mortality in humans.41
Pain Management and Sedation
Adequate pain control is important for patient comfort and to avoid an increase in ICP secondary to increased cerebral metabolic rate. Opioids are commonly used, have minimal cardiovascular effects, and are easily reversed. A constant rate infusion of a full µ-agonist (e.g., fentanyl) is recommended because it provides a more consistent analgesia level. The recommended dose for fentanyl is 2 to 6 µg/kg/hr. Naloxone can be used as a reversal agent if needed.
Benzodiazepines are a great choice for the use of sedation and/or anxiolytics, as they have a minimal effect on ICP and the cardiovascular/respiratory system. α2 Agonists, such as dexmedetomidine, are a potential choice that provides excellent sedation, anxiolysis, and analgesia without causing respiratory depression and is reversible. However, the use of dexmedetomidine in head trauma is controversial because, although it may have neuroprotective properties, it can be associated with more hypotension in human patients.42,43
Nutritional Support
Patients with a TBI have a high rate of metabolism and catabolism. Early nutritional support is important as it helps maintain the integrity of the gastrointestinal mucosa, improves immune function, and lessens the metabolic response to stress.44 Early (within 5 to 7 days) nutritional support in humans after a TBI is associated with a reduced mortality rate.45 The caloric need ranges from 87% to 200% above normal in TBI patients.46 Enteral nutrition (nasogastric or esophagostomy tubes) is used in veterinary patients if they are unable to consume sufficient calories. Prokinetic medications should be used concurrently as patients with TBI often have delayed gastric emptying.
Antibiotics
Antibiotics are indicated in the presence of shock, open wounds, open fractures of the calvarium (especially basilar or sinus fractures), and foreign material embedded into the brain parenchyma. Antibiotics should be lipid soluble to facilitate crossing the BBB and have bactericidal properties.2
Surgical Therapy
A recent study in humans with TBI showed that patients who underwent a decompressive craniotomy had a lower mortality rate than patients who received standard medical care.47 Indications for craniotomy in veterinary patients with TBI include removal of epidural or subdural hematomas, decompression of skull fractures, removal of foreign materials lodged into the brain parenchyma, achieving hemostasis, and decompression for progressive neurologic deterioration.
Monitoring of Head Trauma Patients
Physical examinations (including vital signs and perfusion parameters) and neurologic assessments (including serial SACS scores) should be performed frequently, with a gradual taper as the patient stabilizes. In general, veterinary patients in critical condition should be monitored every 15 to 60 minutes, those in serious condition every 30 to 90 minutes, those in fair condition every 2 to 4 hours, and those in good condition every 4 to 6 hours.2
The electrocardiogram is monitored initially in patients with thoracic trauma as arrhythmias are a common cause of traumatic myocarditis in trauma patients.48
Blood pressure should be monitored closely and maintained at a minimum of 100 mm Hg systolic pressure to maintain adequate CPP. Additionally, blood pressure should always be evaluated in the face of bradycardia to evaluate for the Cushing reflex.
ICP monitoring is the gold standard in the treatment of human patients with TBI. However, the high cost, technical challenges, and invasiveness limit its use in veterinary patients.2,49-51
Prognosis for Head Trauma Patients
TBI can be associated with several complications, including coagulopathies, pneumonia, sepsis, generalized hypothalamic-pituitary dysfunction (including transient or permanent diabetes insipidus), and seizures.52,53 Patients with severe head trauma have a guarded to poor prognosis with lower SACS scores (<8). Dogs and cats can have a great recuperative ability after a TBI and can have successful outcomes with aggressive and appropriate therapy.54 One of the best indicators of prognosis is serial SACS scores. It is important to note that even if the initial SACS score is low (e.g., a grave prognosis), if SACS scores improve with time, a more favorable outcome can be predicted.2 In one study, the probability of death or permanent, severe disability in a dog following TBI was >90% with a SACS score of ≤8 and <10% in patients with a SACS score of ≥10 on initial evaluation.21
In addition to serial clinical and neurologic evaluation, KCTS may also be a helpful prognostic indicator, with a score of ≤3 points being associated with survival with 85% sensitivity and 100% specificity in one study.55 A different study found that post-TBI CT findings may have a limited prognostic significance but that CT is still a valuable tool in identifying structural abnormalities.40 MRI is useful in predicting prognosis when evaluating MRI grade (1 for normal parenchyma and 5 for bilateral brainstem lesions with or without other lesions). One study found a negative correlation between MRI grade and prognosis. In dogs, injuries of the caudal fossa or caudal and rostral fossa had worse outcomes.56 In cats, this location was not statistically significantly associated with a worse outcome.57
A high lactate concentration has been shown to be a negative prognostic indicator in some studies, but conflicting results were found in other studies.12,15,58 Ionized hypocalcemia is a negative prognostic indicator.15 In humans, hyperglycemia is a negative prognostic indicator because of the acceleration of secondary brain injury.29,59 In veterinary patients, those with severe TBI may have hyperglycemia, although it has not always been a proven prognostic indicator.1 More recent data suggest that a higher glucose concentration on admission is a negative prognostic indicator in dogs but not in cats.60
In humans with TBI, presence of coagulopathy is associated with an increase in morbidity and mortality.61 In veterinary patients, an increase in partial thromboplastin time/prothrombin time is correlated with a lower MGCS score and thus may be a prognostic indicator.62
Maintaining adequate CPP is one of the most important factors in the treatment of patients with TBI, and hypotension with a MAP <100 mm Hg is a negative prognostic indicator.63
Severe concurrent injuries noted by a high ATT score, poor perfusion, and requirement for administration of hypertonic saline or endotracheal intubation are poor prognostic indicators.14
Summary
TBI is a frequent component of head trauma in small animals, and prognosis can be good with expedient and aggressive treatment. Treatment is aimed at maintaining normal CPP and reducing ICP, as well as supportive care and frequent monitoring. In some cases, surgery may be warranted. Maintaining a MAP ≥90 mm Hg with a systolic ≥100 mm Hg and an Spo2 ≥95% is very important. Performing serial SACS scores is the best way to estimate prognosis.
References
1. Syring RS, Otto CM, Drobatz KJ. Hyperglycemia in dogs and cats with head trauma: 122 cases (1997-1999). JAVMA. 2001;218(7):1124-1129. doi:10.2460/javma.2001.218.1124
2. Shores A. Treatment and prognosis of head trauma. In: Proceedings of the 13th Annual Kal Kan Symposium for the Treatment of Small Animal Diseases. Kal Kan Foods; 1990:29-36.
3. Dewey CW, Downs MO, Aron DN, Mahaffey EA. Acute traumatic intracranial haemorrhage in dogs and cats. Vet Comp Orthop Traumatol. 1993;6(3):153-159. doi:10.1055/s-0038-1633114
4. Platt SR, Radaelli ST, McDonnell JJ. Computed tomography after mild head trauma in dogs. Vet Rec. 2002;151(8):243. doi:10.1136/vr.151.8.243
5. Platt SR, Adams V, McConnell F, et al. Magnetic resonance imaging evaluation of head trauma in 32 dogs; associations with modified Glasgow Coma Score and patient outcome. Paper presented at: 19th Annual ESVN & ECVN Symposium; September 30, 2006; Barcelona, Spain.
6. Chesnut RM. The management of severe traumatic brain injury. Emerg Med Clin North Am. 1997;15(3):581-604. doi:10.1016/s0733-8627(05)70319-9
7. Brown SA, Hall ED. Role of oxygen-derived free radicals in the pathogenesis of shock and trauma, with focus on central nervous system injuries. JAVMA. 1992;200(12):1849-1859.
8. Ikeda Y, Long DM. The molecular basis of brain injury and brain edema: the role of oxygen free radicals. Neurosurgery. 1990;27(1):1-11. doi:10.1097/00006123-199007000-00001
9. Dietrich WD, Chatzipanteli K, Vitarbo E, Wada K, Kinoshita K. The role of inflammatory processes in the pathophysiology and treatment of brain and spinal cord trauma. Acta Neurochir Suppl. 2004;89:69-74. doi:10.1007/978-3-7091-0603-7_9
10. Rockar RA, Drobatz KS, Shofer FS. Development of a scoring system for the veterinary trauma patient. J Vet Emerg Crit Care. 1994;4(2):77-83. doi:10.1111/j.1476-4431.1994.tb00118.x
11. Ash K, Hayes GM, Goggs R, Sumner JP. Performance evaluation and validation of the animal trauma triage (ATT) score and modified Glasgow Coma Scale with suggested category adjustment in dogs—a VetCOT Registry study. J Vet Emerg Crit Care (San Antonio). 2018;28(3):192-200. doi:10.1111/vec.12717
12. Hall KE, Holowaychuk MK, Sharp CR, Reineke E. Multicenter prospective evaluation of dogs with trauma. JAVMA. 2014;244(3):300-308. doi:10.2460/javma.244.3.300
13. Lapsley J, Hayes GM, Sumner JP. Performance evaluation and validation of the Animal Trauma Triage score and modified Glasgow Coma Scale in injured cats: a Veterinary Committee on Trauma registry study. J Vet Emerg Crit Care (San Antonio). 2019;29(5):478-483. doi:10.1111/vec.12885
14. Sharma D, Holowaychuk MK. Retrospective evaluation of prognostic indicators in dogs with head trauma: 72 cases (January–March 2011). J Vet Emerg Crit Care (San Antonio). 2015;25(5):631-639. doi:10.1111/vec.12328
15. Chik C, Hayes GM, Menard J. Development of a veterinary trauma score (VetCOT) in canine trauma patients with performance evaluation and comparison to the animal trauma triage score: a VetCOT registry study. J Vet Emerg Crit Care (San Antonio). 2021;31(6):708-717. doi:10.1111/vec.13135
16. Hughes D. Pulmonary edema. In: King LG, ed. Textbook of Respiratory Disease in Dogs and Cats. Saunders; 2004:487-497.
17. Drobatz KJ, Saunders HM, Pugh CR, Hendricks JC. Noncardiogenic pulmonary edema in dogs and cats: 26 cases (1987–1993). JAVMA. 1995;206(11):1732-1736.
18. Lord PF. Neurogenic pulmonary edema in the dog. JAAHA.
1975;11:778-783.
19. Drobatz KJ, Saunders HM. Noncardiogenic pulmonary edema. In: Bonagura JD, Twedt DC, eds. Kirk’s Current Veterinary Therapy XIV. 14th ed. Saunders Elsevier; 2009:663-665.
20. Sande A, West C. Traumatic brain injury: a review of pathophysiology and management. J Vet Emerg Crit Care (San Antonio). 2010;20(2):177-190. doi:10.1111/j.1476-4431.2010.00527.x
21. Shores A. Small Animal Coma Scale revisited. In: Proceedings of the 10th Annual Veterinary Medical Forum. American College of Veterinary Internal Medicine; 1992:749-749.
22. Battison C, Andrews PJD, Graham C, Petty T. Randomized, controlled trial on the effect of a 20% mannitol solution and a 7.5% saline/6% dextran solution on increased intracranial pressure after brain injury. Crit Care Med. 2005;33(1):196-202, 257-258. doi:10.1097/01.ccm.0000150269.65485.a6
23. Bratton SL, Chesnut RM, Ghajar J, et al. Guidelines for the management of severe traumatic brain injury. II. Hyperosmolar therapy. J Neurotrauma. 2007;24(suppl 1):S14-S20. doi:10.1089/neu.2007.9994
24. Cruz J, Minoja G, Okuchi K, Facco E. Successful use of the new high-dose mannitol treatment in patients with Glasgow Coma Scale scores of 3 and bilateral abnormal pupillary widening: a randomized trial. J Neurosurg. 2004;100(3):376-383. doi:10.3171/jns.2004.100.3.0376
25. Ng I, Lim J, Wong HB. Effects of head posture on cerebral hemodynamics: its influences on intracranial pressure, cerebral perfusion pressure, and cerebral oxygenation. Neurosurgery. 2004;54(3):593-598. doi:10.1227/01.neu.0000108639.16783.39
26. Biddick AA, Bacek LM, Taylor AR. A serious adverse event secondary to rapid intravenous levetiracetam injection in a dog. J Vet Emerg Crit Care (San Antonio). 2018;28(2):157-162. doi:10.1111/vec.12693
27. Jeremitsky E, Omert LA, Dunham CM, Wilberger J, Rodriguez A. The impact of hyperglycemia on patients with severe brain injury. J Trauma. 2005;58(1):47-50. doi:10.1097/01.ta.0000135158.42242.b1
28. Rovlias A, Kotsou S. The influence of hyperglycemia on neurological outcome in patients with severe head injury. Neurosurgery. 2000;46(2):335-343. doi:10.1097/00006123-200002000-00015
29. Cherian L, Hannay HJ, Vagner G, Goodman JC, Contant CF, Robertson CS. Hyperglycemia increases neurological damage and behavioral deficits from post-traumatic secondary ischemic insults. J Neurotrauma. 1998;15(5):307-321. doi:10.1089/neu.1998.15.307
30. Lagares A, Ramos A, Pérez-Nuñez A, et al. The role of MR imaging in assessing prognosis after severe and moderate head injury. Acta Neurochir (Wien). 2009;151(4):341-356. doi:10.1007/s00701-009-0194-8
31. Chai O, Peery D, Bdolah-Abram T, et al. Computed tomographic findings in dogs with head trauma and development of a novel prognostic computed tomography–based scoring system. Am J Vet Res. 2017;78(9):1085-1090. doi:10.2460/ajvr.78.9.1085
32. Chesnut RM, Marshall LF, Klauber MR, et al. The role of secondary brain injury in determining outcome from severe head injury. J Trauma. 1993;34(2):216-222. doi:10.1097/00005373-199302000-00006
33. Wisner D, Busche F, Sturm J, Gaab M, Meyer H. Traumatic shock and head injury: effects of fluid resuscitation on the brain. J Surg Res. 1989;46(1):49-59. doi:10.1016/0022-4804(89)90181-9
34. Fairman NB. Evaluation of pulse oximetry as a continuous monitoring technique in critically ill dogs in the small animal intensive care unit. J Vet Emerg Crit Care. 1992;2(2):50-56. doi:10.1111/j.1476-4431.1992.tb00092.x
35. Hendricks JC, King LG. Practicality, usefulness, and limits of pulse oximetry in critical small animal patients. J Vet Emerg Crit Care. 1993;3(1):5-12. doi:10.1111/j.1476-4431.1993.tb00098.x
36. Bratton SL, Chesnut RM, Ghajar J, et al. Guidelines for the management of severe traumatic brain injury. XIII. Antiseizure prophylaxis. J Neurotrauma. 2007;24(suppl 1):S83-S86. doi:10.1089/neu.2007.9983
37. Wyatt S, Llabres-Diaz F, Lee CY, Beltran E. Early CT in dogs following traumatic brain injury has limited value in predicting short-term prognosis. Vet Radiol Ultrasound. 2021;62(2):181-189. doi:10.1111/vru.12933
38. Beltran E, Platt SR, McConnell JF, Dennis R, Keys DA, De Risio L. Prognostic value of early magnetic resonance imaging in dogs after traumatic brain injury: 50 cases. J Vet Intern Med. 2014;28(4):1256-1262. doi:10.1111/jvim.12368
39. Temkin NR, Dikmen SS, Wilensky AJ, Keihm J, Chabal S, Winn HR. A randomized, double-blind study of phenytoin for the prevention of post-traumatic seizures. N Engl J Med. 1990;323(8):497-502. doi:10.1056/NEJM199008233230801
40. Carney N, Totten AM, O’Reilly C, et al. Guidelines for the management of severe traumatic brain injury, fourth edition. Neurosurgery. 2017;80(1):6-15. doi:10.1227/NEU.0000000000001432
41. Edwards P, Arango M, Balica L, et al. Final results of MRC CRASH, a randomised placebo-controlled trial of intravenous corticosteroid in adults with head injury-outcomes at 6 months. Lancet. 2005;365(9475):1957-1959. doi:10.1016/S0140-6736(05)66552-X
42. Pajoumand M, Kufera JA, Bonds BW, et al. Dexmedetomidine as an adjunct for sedation in patients with traumatic brain injury. J Trauma Acute Care Surg. 2016;81(2):345-351. doi:10.1097/TA.0000000000001069
43. Wu J, Vogel T, Gao X, Lin B, Kulwin C, Chen J. Neuroprotective effect of dexmedetomidine in a murine model of traumatic brain injury. Sci Rep. 2018;8(1):4935. doi:10.1038/s41598-018-23003-3
44. Marik PE, Varon J, Trask T. Management of head trauma. Chest. 2002;122(2):699-711. doi:10.1378/chest.122.2.699
45. Härtl R, Gerber LM, Ni Q, Ghajar J. Effect of early nutrition on deaths due to severe traumatic brain injury. J Neurosurg. 2008;109(1):50-56. doi:10.3171/JNS/2008/109/7/0050
46. Abdullah MI, Ahmad A, Wafa SW, et al. Determination of calorie and protein intake among acute and sub-acute traumatic brain injury patients. Chin J Traumatol. 2020;23(5):290-294. doi:10.1016/j.cjtee.2020.04.004
47. Hutchinson PJ, Kolias AG, Timofeev IS, et al. Trial of decompressive craniectomy for traumatic intracranial hypertension. N Engl J Med. 2016;375(12):1119-1130. doi:10.1056/NEJMoa1605215
48. Marcolini EG, Keegan J. Blunt cardiac injury. Emerg Med Clin North Am. 2015;33(3):519-527. doi:10.1016/j.emc.2015.04.003
49. Dewey CW, Bailey CS, Haskins SC, Kass PH, Crowe DT. Evaluation of an epidural intracranial pressure monitoring system in cats. J Vet Emerg Crit Care. 1997;7(1):20-33. doi:10.1111/j.1476-4431.1997.tb00041.x
50. Ilie LA, Thomovsky EJ, Johnson PA, et al. Relationship between intracranial pressure as measured by an epidural intracranial pressure monitoring system and optic nerve sheath diameter in healthy dogs. Am J Vet Res. 2015;76(8):724-731. doi:10.2460/ajvr.76.8.724
51. Bagley RS, Keegan RD, Greene SA, Moore MP, Gavin PR. Intraoperative monitoring of intracranial pressure in five dogs with space-occupying intracranial lesions. JAVMA. 1995;207(5):588-591.
52. Piek J, Chesnut RM, Marshall LF, et al. Extracranial complications of severe head injury. J Neurosurg. 1992;77(6):901-907. doi:10.3171/jns.1992.77.6.0901
53. Foley C, Bracker K, Drellich S. Hypothalamic–pituitary axis deficiency following traumatic brain injury in a dog. J Vet Emerg Crit Care (San Antonio). 2009;19(3):269-274. doi:10.1111/j.1476-4431.2009.00409.x
54. Sorjonen DC, Thomas WB, Myers LJ, Cox NR. Radical cerebral cortical resection in dogs. Prog Vet Neurol. 1991;2(4):225-236.
55. Rapoport K, Mateo I, Peery D, et al. The prognostic value of the Koret CT score in dogs following traumatic brain injury. Vet J. 2020;266:105563. doi:10.1016/j.tvjl.2020.105563
56. Yanai H, Tapia-Nieto R, Cherubini GB, Caine A. Results of magnetic resonance imaging performed within 48 hours after head trauma in dogs and association with outcome: 18 cases (2007–2012). JAVMA. 2015;246(11):1222-1229. doi:10.2460/javma.246.11.1222
57. Caine A, Brash R, De Risio L, Van Dijk J, Cherubini GB, Dennis R. MRI in 30 cats with traumatic brain injury. J Feline Med Surg. 2019;21(12):1111-1119. doi:10.1177/1098612X18819162
58. Simpson SA, Syring R, Otto CM. Severe blunt trauma in dogs: 235 cases (1997–2003). J Vet Emerg Crit Care (San Antonio). 2009;19(6):588-602. doi:10.1111/j.1476-4431.2009.00468.x
59. Shi J, Dong B, Mao Y, et al. Review: traumatic brain injury and hyperglycemia, a potentially modifiable risk factor. Oncotarget. 2016;7(43):71052-71061. doi:10.18632/oncotarget.11958
60. Cameron S, Weltman JG, Fletcher DJ. The prognostic value of admission point-of-care testing and modified Glasgow Coma Scale score in dogs and cats with traumatic brain injuries (2007–2010): 212 cases. J Vet Emerg Crit Care (San Antonio). 2022;32(1):75-82. doi:10.1111/vec.13108
61. Maegele M, Schöchl H, Menovsky T, et al. Coagulopathy and haemorrhagic progression in traumatic brain injury: advances in mechanisms, diagnosis, and management. Lancet Neurol. 2017;16(8):630-647. doi:10.1016/S1474-4422(17)30197-7
62. Riese F, Rohn K, Hoppe S, Tipold A. Hypernatremia and coagulopathy may or may not be useful clinical biomarkers in dogs with head trauma: a retrospective study. J Neurotrauma. 2018;35(23):2820-2826. doi:10.1089/neu.2016.4620
63. Kinoshita K. Traumatic brain injury: pathophysiology for neurocritical care. J Intensive Care. 2016;4:29. doi:10.1186/s40560-016-0138-3